Download Free Pass4sure 4H0-004 exam Real Exam Questions

Killexams.com 4H0-004 Real Exam Questions comprises of 4H0-004 Exam Questions in PDF record configuration and VCE test system in Installable programming. Both of the 4H0-004 braindumps and Study Guide are completely refreshed before it opens up in your download area. Set aside your time and cash, simply register and download.

Exam Code: 4H0-004 Practice exam 2022 by Killexams.com team
HCP-Hyperion System 9 Financial Management 4.1
Hyperion learning
Killexams : Hyperion learning - BingNews http://www.bing.com:80/news/search?q=Hyperion+learning&cc=us&format=RSS Search results Killexams : Hyperion learning - BingNews http://www.bing.com:80/news/search?q=Hyperion+learning&cc=us&format=RSS https://killexams.com/exam_list/Hyperion Killexams : SEERIST ESTABLISHES THE FIRST AUGMENTED ANALYTICS TECHNOLOGY FOR SECURITY AND THREAT INTELLIGENCE PROFESSIONALS

Seerist offers unrivaled security and risk intelligence using real-time artificial intelligence being learned by human analysis

HERNDON, Va., Aug. 2, 2022 /CNW/ -- Seerist, Inc. launches today as the world's leading solution provider of augmented analytics for security and threat intelligence professionals. The new company merges Control Risks' CORE online platform with the machine learning backbone from Geospark Analytics' Hyperion platform.

Seerist offers unrivaled security and risk intelligence using real-time AI being learned by human analysis.

Seerist provides the only augmented analytics solution that integrates continuous-learning expert, in-location human analysis with artificial intelligence (AI) algorithms specifically designed to deliver early, actionable and strategic insight for corporations, non-governmental organizations (NGOs) and government organizations.

Seasoned Leaders Guiding Seerist
Leading the new company are seasoned executives who bring broad experience from Geospark Analytics and Control Risks:

  • Jim Brooks, former Control Risks Chief Operations Officer, is leading Seerist as its Chief Executive Officer

  • John Goolgasian, former Geospark Analytics President, is Seerist's Chief Product and Innovation Officer

  • Eddie Everett is Chief Growth Officer at Seerist after leading Control Risks' Products and Partnerships

"Seerist is solely focused on delivering the most advanced threat and risk intelligence solution on the market. Continuously enhancing and expanding the capabilities of the solution is our only mission, in order to ensure clients have the data and information they need to make critical decisions to help them save people, assets, resources, and time," said Jim Brooks, Seerist's CEO. "The extent of critical, yet unsolved challenges facing businesses and governments in the threat and risk marketplace is unpalatable. Seerist is uniquely positioned to change that dynamic."

Accelerating a Vision
With the launch of Seerist, Control Risks and Geospark Analytics leaders are accelerating their vision to create an organization solely focused on harnessing the power of AI and expert human analysis, enabling them to innovate threat and risk intelligence solutions much quicker.

"Control Risks' investment in Seerist and spinning off of our online monitoring platform is a game-changing move for the industry," said Nick Allan, Control Risks' CEO. "It will supercharge the technology-enabled analysis solutions we are able to offer clients, giving them what they need to better run their businesses and protect their people and assets."

"The time is right; increased computer power, machine-learning algorithms, and data ubiquity truly enable the promise of applied artificial intelligence and machine learning for the risk and threat space," said Omar Balkissoon, Geospark Analytics' founder and CEO. "The valuable predictive intelligence that Seerist is able to deliver today to clients is going to grow with orders of magnitude. It's going to be exciting to watch how Seerist continues to enhance and develop the solution over the next several years."

Combined Expert Capabilities Deliver Impactful Results
Seerist brings together an array of talent, including Geospark Analytics' software developers, engineers, and data scientists with Control Risks' online intelligence and content experts, and client support, sales, and product management teams from both organizations.

The combined global organization empowers the Seerist solution to automate the collection of millions of datasets from across the globe to assess activity anomalies, stability shifts, volatility swings, variations in political and popular sentiment, and much more. Its algorithms eliminate the noise before seasoned, in-location analysts verify the activity. The intuitive Seerist dashboard delivers industry-leading, real-time insights with enhanced accuracy and relevance allowing security and operational users to make rapid and reliable decisions, as well as strategic analysis of trends over longer time horizons.

About Seerist, Inc.
Seerist, Inc. enables global corporations, governments, and organizations to navigate a volatile and uncertain world by preparing them for potential events that could be highly disruptive to their operations. Seerist is the first augmented analytics solution for risk and threat analysis, delivering greater levels of accuracy and relevance than any alternative technology or service. It combines cutting-edge artificial intelligence (AI) and machine-learning (ML) technology parsing millions of data points with human analysis drawing on decades of insight, enabling users to better predict what will happen and allowing them to make rapid, strategic, and reliable decisions when it matters most. To learn more, visit www.seerist.com.

About Control Risks
Control Risks is a global specialist risk consultancy that helps to create secure, compliant and resilient organisations in an age of ever-changing risk. Working across disciplines, technologies, and geographies, everything we do is based on our belief that taking risks is essential to our clients' success. We provide you with the insight to focus resources and ensure you are prepared to resolve the issues and crises that occur in any ambitious global organisation. We go beyond problem-solving and supply you the insight and intelligence you need to realise opportunities and grow.

Seerist is a trademark of Seerist, Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.

Seerist Inc. launches with the first augmented analytics technology for security and threat intelligence professionals.

Cision

View original content to obtain multimedia:https://www.prnewswire.com/news-releases/seerist-establishes-the-first-augmented-analytics-technology-for-security-and-threat-intelligence-professionals-301596569.html

SOURCE Seerist, Inc.

Cision

View original content to obtain multimedia: http://www.newswire.ca/en/releases/archive/August2022/02/c7578.html

Mon, 01 Aug 2022 17:00:00 -0500 en-US text/html https://finance.yahoo.com/news/seerist-establishes-first-augmented-analytics-050000754.html
Killexams : Logitech G402 Hyperion Fury review: "still as comfortable as ever" No result found, try new keyword!The Logitech G402 Hyperion Fury is getting on a little now, but that means it's perfectly primed to offer a budget alternative to the latest releases. Where some of the best gaming mouse models can ... Tue, 26 Jul 2022 02:36:50 -0500 en-us text/html https://www.msn.com/en-us/entertainment/gaming/logitech-g402-hyperion-fury-review-still-as-comfortable-as-ever/ar-AA1002nR Killexams : David Lott Sees His Stories Published

On June 28, David Lott released Back in Brookford: Stories through Nichols Street Press, his self-publishing imprint, with distribution through IngramSpark. Based on Lott’s Staunton, Va., upbringing, the stories use details common to late-20th-century life as anchors for eerie and unsettling events. “Clearly these stories came from having grown up in a place like Brookford,” said Robin Straus, Lott’s literary agent. “While the stories aren’t precisely interconnected, the ties between characters wind up giving a very well-rounded portrait of a place.”

Shortly after it was released, Lott received a bound copy of Back in Brookford, and a few days later, on July 10, he died from pancreatic cancer at age 59, leaving behind his wife, Jenny Gillis, and their children Eleanor Gillis Lott and James David Lott III. Back in Brookford is the culmination of a life spent writing and working in book publishing—Lott was a production editor for Hyperion and was most recently a senior managing editor at Macmillan.

To get his book published, Lott had to defy the odds of his cancer, surviving five years past his diagnosis and providing real hope to the medical staff at his hospital when he came in for checkups. When his cancer returned in spring 2021, Lott partook in an experimental drug trial at Dana-Farber Cancer Institute in Boston, and his tumor markers kept shrinking. He returned to work at Macmillan.

In late spring of this year, however, Lott learned his health had taken a turn for the worse. “He knew he was on borrowed time,” said Lott’s colleague Michelle McMillian, associate director of design at Macmillan. “Since his book hadn’t sold, he decided to self-publish. He wanted something in the world that was part of him. I decided to design the book to make sure he got to have something he’s been working toward for so long.”

Straus was disappointed she wasn’t able to find a publisher for Back in Brookford, but said that was “a reflection on the marketplace and not on the quality of the writing, which was superb.”

She wasn’t alone in that opinion; Lott had a longtime friend and champion in Will Schwalbe, who is currently an executive v-p at Macmillan. “Starting way back at Hyperion, it was always kind of a banner day when David would come in with some incredibly funny story,” said Schwalbe, who, in addition to his editorial work at Macmillan, is known for his own books, which include The End of Your Life Book Club, about his mother’s death from pancreatic cancer. “Whenever I saw him I would shout out ‘Lott!,’ which became kind of a joke.”

On July 17, Schwalbe wrote a long and heartfelt Facebook post about his friend that encouraged everyone he knew to consider buying a copy of Back in Brookford as a tribute—but also as a treat.

“By the time David showed me this collection of stories that he had worked on for years, I saw that not only was his prose dark, inventive, and funny but that the pieces spoke very deeply of a moment in American society,” Schwalbe said. “In many of these stories, there are no computers, no cell phones, no game stations—just kids wandering around the neighborhood and hanging out in each other’s houses. It’s dispatches from the end of the baby boom.”

Lott’s son agrees that his father’s stories have a distinct atmosphere. “My dad and I connected through books, especially Stephen King’s Stand By Me—books about people who surmount challenges to get to a better place. He also gave my sister and I exploratory childhoods, with long bike rides, time in the natural world and few devices. His book embodies the simultaneous insecurity and beauty in growing up.”

Tom Perrotta, who provided the book’s cover blurb, said that he was struck by “the tension between humor and nostalgia on one hand—always a part of American small-town fiction—and the sudden eruptions of darker material. A lot of what’s funny about life is interwoven with the depressing and disturbing stuff we have to deal with every day, and I think David captures that mixture really well in these stories.” On learning of Lott’s death, Perrotta said he was glad Lott was able to publish his book, adding, “I hope people will find their way to it.”

Schwalbe said Lott was “really beloved” at Macmillan. “It’s easy for people outside of publishing to forget the kind of contribution that a production or managing editor makes to a text, line by line and word by word. He loved the books he worked on and was so proud of them. He devoted his life and career to getting those words exactly the way everyone wanted them. When you read this book, you can tell this was a man who loved storytelling and literature.”

A version of this article appeared in the 08/01/2022 issue of Publishers Weekly under the headline: David Lott Sees His Stories Published

Fri, 29 Jul 2022 11:39:00 -0500 en text/html https://www.publishersweekly.com/pw/by-topic/industry-news/publisher-news/article/89989-david-lott-sees-his-stories-published.html
Killexams : CAMP4’s $100m Series B backs regulatory RNA-led efforts in urea cycle disorders

Last week, CAMP4 Therapeutics announced the close of a $100 million Series B round, which will be used to advance their regulatory RNA (regRNA)-focused programs. Their use of regRNA technology provides a unique approach to treating rare conditions like urea cycle disorders.

CAMP4’s CSO David Bumcrot PhD, tells Pharmaceutical Technology that the company plans to see clinical trials go forward for their urea cycle disorder programs late next year. In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs).

The Series B round was led by Enavate sciences, and existing investors including 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group, and others also participated.

Urea cycle disorders are a group of rare conditions where the ability to remove ammonia from the blood is disrupted, resulting in hyperammonaemia. Current treatments focus on detoxifying ammonia from the blood. However, a new wave of pipeline drugs, including CAMP4’s artificial intelligence (AI)-based regRNA approach, for urea cycle disorders aims to tackle the cause of the disorder rather than the symptoms.

David Bumcrot in the Office for Marauder Therapeutics

The therapeutic landscape

Urea cycle disorders are grouped under a category of disorders caused due to inborn errors of metabolism. Typically, nitrogen in the blood is removed in the form of urea. However, in patients with urea cycle disorders, genetic defects result in inadequate amounts of the enzymes needed to convert nitrogen into urea. This leads to hyperammonaemia, which causes symptoms such as vomiting, mental confusion, and lethargy. Thus many patients take supplements and seek dietary changes to Excellerate their quality of life.

The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder. Drugs for dialysis, amino acid supplements, and drugs which convert blood ammonia are marketed right now as the go-to urea cycle disorder treatments.

In 2013, the US Food and Drug Administration (FDA) approved Ravicti (glycerol phenylbutyrate), manufactured by Hyperion Therapeutics, which has since then been acquired by Horizon Pharma. A nitrogen-binding drug, its global sales were $292m in 2021, as per GlobalData. Other treatments include sodium phenylbutyrate marketed as Buphenyl or Ammonaps.

GlobalData is the parent company of Pharmaceutical Technology.

However, the urea cycle disorder therapeutic landscape is expanding. Ultragenyx Pharmaceuticals has an orthinine transcarbamylase (OTC) activator drug in Phase III trials. The liver OTC enzyme plays a key role in the breakdown of nitrogen in the urea cycle. Ultragenyx uses adeno-associated virus 8 (AAV8) gene therapy to induce stable OTC gene expression. This treatment activates the OTC gene so that ammonia can be removed from the blood.

The University of California Los Angeles are currently investigating the use of genetically altered hepatocyte-like cells generated from induced pluripotent stem cells. This gene therapy will supply the instructions to produce the enzyme arginine so that it can be hydrolysed to ornithine.

CAMP4’s approach to urea cycle disorders

CAMP4 has two programs for the treatment of urea cycle disorders. One solely focuses on OTC deficiency whilst the other program targets the five other enzyme deficiencies that cause urea cycle disorder.

According to Bumcrot, regRNAs are “RNAs that arise out of the non-coding genome”. In CAMP4’s approach, regRNAs are drugged with antisense oligonucleotides to control the direction of gene expression. CAMP4 coined these antisense oligonucleotides as ‘RNA actuators’ due to their ability to increase or decrease the expression of particular genes.

In their urea cycle disorder programs, CAMP4 is targetting gene expression to increase the translation of enzymes downstream. “Taking this approach will treat not only individuals with OTC deficiency, but individuals with deficiencies in any of the other enzymes in the cycle”, states Bumcrot.

In order to find the specific RNA sequences for a genetic disease, the biotech is using an AI- and machine learning-based approach. Their platform identifies which regRNAs control the specific gene of interest. In order to do this, their team has created maps across a range of human cell types, and this allows them to predict which enhancers control specific promoters.

Future possibilities

In order to achieve these plans, CAMP 4’s CEO, Josh Mandel-Brehm stated the company will prioritise raising capital through partnerships and business development. Later this year, they also plan to complete animal toxicology studies that will allow them to go forward with an investigational new drug (IND) application for their candidate to treat urea cycle disorders in 2023, after which the company plans to enter the clinic.

Josh Mandel-Brehm, CEO, CAMP4 Therapeutics

In addition to this, CAMP4 has three other programs for Dravet syndrome, frontotemporal dementia (FTD), and primary biliary cholangitis (PBC). Supported by their latest funding, CAMP4 plans to file an IND and CTA for the Dravet syndrome program in Q1 of 2023, so they can begin treating patients in a study later that year. Due to the rare nature of the disease, the trial will be conducted at multiple sites worldwide. Similar to their urea cycle disorder programs, each of CAMP4’s programs, take a regRNA based approach.

Once clinical trials begin, Bumcrot believes that their regRNA approach “can address probably 80% of patients with urea cycle disorders”.

Related Companies
Fri, 29 Jul 2022 04:48:38 -0500 en-US text/html https://www.pharmaceutical-technology.com/news/camp4s-funding-influx-paves-the-way-for-tapping-regulatory-rna-to-treat-urea-cycle-disorders/
Killexams : Final Fantasy XIV Community Spotlight: LunarCon! No result found, try new keyword!Who doesn’t love a good convention? Exciting panels about interesting Topics from seasoned experts or discussions with your favourite celebrities, competitions, meet and greets, and stunning ... Sat, 06 Aug 2022 07:00:13 -0500 en-us text/html https://www.msn.com/en-us/lifestyle/lifestyle-buzz/final-fantasy-xiv-community-spotlight-lunarcon/ar-AA10nZAD Killexams : Azeron Cyborg review: 'a revolution at your fingertips' No result found, try new keyword!The Azeron Cyborg keypad will certainly make itself known on your desk. The almost creepy robot hand is a statement piece in any setup, and it means business. Who needs a gaming keyboard when you have ... Fri, 22 Jul 2022 00:41:15 -0500 en-us text/html https://www.msn.com/en-us/entertainment/gaming/azeron-cyborg-review-a-revolution-at-your-fingertips/ar-AAZRP6d Killexams : Seerist, Inc.: SEERIST ESTABLISHES THE FIRST AUGMENTED ANALYTICS TECHNOLOGY FOR SECURITY AND THREAT INTELLIGENCE PROFESSIONALS

Seerist offers unrivaled security and risk intelligence using real-time artificial intelligence being learned by human analysis

HERNDON, Va., Aug. 2, 2022 /PRNewswire/ -- Seerist, Inc. launches today as the world's leading solution provider of augmented analytics for security and threat intelligence professionals. The new company merges Control Risks' CORE online platform with the machine learning backbone from Geospark Analytics' Hyperion platform.

Seerist provides the only augmented analytics solution that integrates continuous-learning expert, in-location human analysis with artificial intelligence (AI) algorithms specifically designed to deliver early, actionable and strategic insight for corporations, non-governmental organizations (NGOs) and government organizations.

Seasoned Leaders Guiding Seerist
Leading the new company are seasoned executives who bring broad experience from Geospark Analytics and Control Risks:

  • Jim Brooks, former Control Risks Chief Operations Officer, is leading Seerist as its Chief Executive Officer
  • John Goolgasian, former Geospark Analytics President, is Seerist's Chief Product and Innovation Officer
  • Eddie Everett is Chief Growth Officer at Seerist after leading Control Risks' Products and Partnerships

"Seerist is solely focused on delivering the most advanced threat and risk intelligence solution on the market. Continuously enhancing and expanding the capabilities of the solution is our only mission, in order to ensure clients have the data and information they need to make critical decisions to help them save people, assets, resources, and time," said Jim Brooks, Seerist's CEO. "The extent of critical, yet unsolved challenges facing businesses and governments in the threat and risk marketplace is unpalatable. Seerist is uniquely positioned to change that dynamic."

Accelerating a Vision
With the launch of Seerist, Control Risks and Geospark Analytics leaders are accelerating their vision to create an organization solely focused on harnessing the power of AI and expert human analysis, enabling them to innovate threat and risk intelligence solutions much quicker.

"Control Risks' investment in Seerist and spinning off of our online monitoring platform is a game-changing move for the industry," said Nick Allan, Control Risks' CEO. "It will supercharge the technology-enabled analysis solutions we are able to offer clients, giving them what they need to better run their businesses and protect their people and assets."

"The time is right; increased computer power, machine-learning algorithms, and data ubiquity truly enable the promise of applied artificial intelligence and machine learning for the risk and threat space," said Omar Balkissoon, Geospark Analytics' founder and CEO. "The valuable predictive intelligence that Seerist is able to deliver today to clients is going to grow with orders of magnitude. It's going to be exciting to watch how Seerist continues to enhance and develop the solution over the next several years."

Combined Expert Capabilities Deliver Impactful Results
Seerist brings together an array of talent, including Geospark Analytics' software developers, engineers, and data scientists with Control Risks' online intelligence and content experts, and client support, sales, and product management teams from both organizations.

The combined global organization empowers the Seerist solution to automate the collection of millions of datasets from across the globe to assess activity anomalies, stability shifts, volatility swings, variations in political and popular sentiment, and much more. Its algorithms eliminate the noise before seasoned, in-location analysts verify the activity. The intuitive Seerist dashboard delivers industry-leading, real-time insights with enhanced accuracy and relevance allowing security and operational users to make rapid and reliable decisions, as well as strategic analysis of trends over longer time horizons.

About Seerist, Inc.
Seerist, Inc. enables global corporations, governments, and organizations to navigate a volatile and uncertain world by preparing them for potential events that could be highly disruptive to their operations. Seerist is the first augmented analytics solution for risk and threat analysis, delivering greater levels of accuracy and relevance than any alternative technology or service. It combines cutting-edge artificial intelligence (AI) and machine-learning (ML) technology parsing millions of data points with human analysis drawing on decades of insight, enabling users to better predict what will happen and allowing them to make rapid, strategic, and reliable decisions when it matters most. To learn more, visit www.seerist.com.

About Control Risks
Control Risks is a global specialist risk consultancy that helps to create secure, compliant and resilient organisations in an age of ever-changing risk. Working across disciplines, technologies, and geographies, everything we do is based on our belief that taking risks is essential to our clients' success. We provide you with the insight to focus resources and ensure you are prepared to resolve the issues and crises that occur in any ambitious global organisation. We go beyond problem-solving and supply you the insight and intelligence you need to realise opportunities and grow.

Seerist is a trademark of Seerist, Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.

Video - https://www.youtube.com/watch?v=bYzLTcLI1Do
Logo - https://mma.prnewswire.com/media/1869632/Seerist_Logo.jpg

Mon, 07 Feb 2022 15:03:00 -0600 de text/html https://www.finanznachrichten.de/nachrichten-2022-08/56699394-seerist-inc-seerist-establishes-the-first-augmented-analytics-technology-for-security-and-threat-intelligence-professionals-008.htm
4H0-004 exam dump and training guide direct download
Training Exams List